Hemorrhagic Presentation in Primary Central Nervous System Lymphoma: A Case Study
- PMID: 38561939
- PMCID: PMC11000205
- DOI: 10.12659/AJCR.942951
Hemorrhagic Presentation in Primary Central Nervous System Lymphoma: A Case Study
Abstract
BACKGROUND Primary central nervous system diffuse large B-cell lymphoma (DLBCL) is an extremely aggressive brain disease that rarely affects immunocompetent non-elderly patients, particularly with hemorrhagic presentation. Brain magnetic resonance imaging (MRI) plays an important role in the diagnosis of this entity, which typically demonstrates restricted diffusion and a T2 hypointense appearance, suggesting hypercellularity. CASE REPORT A 44-year-old man came to the emergency department with a persistent and treatment-resistant bilateral frontal headache that had been bothering him for the past 3 weeks. Upon conducting a neurological assessment, the patient displayed temporal disorientation and incoherent speech, but without any observable motor deficits. A non-contrast enhanced brain computed tomography scan was carried out, revealing a hyperattenuating, space-occupying lesion and hemorrhage in the left hemisphere of the brain. Subsequently, brain MRI demonstrated hypointense signal on T2-weighted images, restricted diffusion, and homogeneous lesional contrast enhancement, suggesting a very cellular expansive lesion with hemorrhage. To establish a definitive diagnosis, a brain biopsy was undertaken, confirming the presence of DLBCL of the primary central nervous system (germinal center phenotype). CONCLUSIONS Hemorrhagic presentation of primary central nervous system DLBCL occurs very rarely, particularly in non-elderly immunocompetent patients. Brain MRI plays an important role in the diagnosis of this entity, which allows differentiation from high-grade glial or other lesions that present more frequently with hemorrhage. Therefore, it is crucial to suspect lymphoma before surgical intervention for appropriate patient management.
Conflict of interest statement
Figures


Similar articles
-
Delayed Contrast Enhancement in Magnetic Resonance Imaging and Vascular Morphology of Primary Diffuse Large B-Cell Lymphoma (DLBCL) of the Central Nervous System (CNS): A Retrospective Study.Med Sci Monit. 2019 May 5;25:3321-3328. doi: 10.12659/MSM.913439. Med Sci Monit. 2019. PMID: 31055591 Free PMC article.
-
Multifocal hemosiderin depositions on T2*-weighted magnetic resonance imaging in a patient with pathology-proven systemic diffuse large B-cell lymphoma.BMC Neurol. 2014 Sep 25;14:184. doi: 10.1186/s12883-014-0184-1. BMC Neurol. 2014. PMID: 25252760 Free PMC article.
-
Primary central nervous system lymphomas with massive intratumoral hemorrhage: Clinical, radiological, pathological, and molecular features of six cases.Neuropathology. 2021 Oct;41(5):335-348. doi: 10.1111/neup.12739. Epub 2021 Jul 13. Neuropathology. 2021. PMID: 34254378
-
Inflammatory brain lesions preceding primary central nervous system lymphoma: a case report and genetic analysis.Neurol Sci. 2023 May;44(5):1555-1561. doi: 10.1007/s10072-022-06587-7. Epub 2023 Jan 5. Neurol Sci. 2023. PMID: 36599976 Free PMC article. Review.
-
A Rare Case of Spontaneous Remission and Relapse of a Primary Central Nervous System Lymphoma.Acta Med Port. 2018 Dec 28;31(12):777-783. doi: 10.20344/amp.10198. Epub 2018 Dec 28. Acta Med Port. 2018. PMID: 30684376 Review.
References
-
- Pons-Escoda A, Naval-Baudin P, Velasco R, Vidal N, Majós C. Imaging of lymphomas involving the CNS: An update-review of the full spectrum of disease with an emphasis on the World Health Organization Classifications of CNS Tumors 2021 and Hematolymphoid Tumors 2022. Am J Neuroradiol. 2023;44(4):358–66. - PMC - PubMed
-
- Jhaveri MD, Osborn AG, Salzman KL, Jhaveri MD. Chapter 173: Diffuse large B-cell lymphoma. In: Jhaveri MD, Osborn AG, Salzman KL, editors. Diagnostic imaging: Brain. 4th ed. Philadelphia, PA: Elsevier; 2020. pp. 602–6.
-
- Visco C, Tzankov A, Xu-Monette ZY, et al. Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study. Haematologica. 2013;98(2):255–63. - PMC - PubMed
-
- Marcus C, Maragkos GA, Alterman RL, Uhlmann E, Pihan G, Varma H. GCB-type is a favorable prognostic factor in primary CNS diffuse large B-cell lymphomas. J Clin Neurosci. 2020;83:49–55. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous